VirIntel LLC is a diagnostic and research startup involved in a broad spectrum of projects concerning COVID-19.  VirIntel immunology, bioinformatics and assay development experts have designed a dual-parameter serological test with 100% specificity, which allows to determine if a person’s immune system has created antibodies against the SARS-Cov-2.